SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-16-119622
Filing Date
2016-05-12
Accepted
2016-05-12 17:15:22
Documents
2
Period of Report
2016-05-12

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 3369
2 POA DOCUMENT poa.txt EX-24.3_653790 3572
  Complete submission text file 0001209191-16-119622.txt   8248
Mailing Address 7 CLARKE DRIVE CRANBURY NJ 08512
Business Address 7 CLARKE DRIVE CRANBURY NJ 08512 6096193990
Oncobiologics, Inc. (Issuer) CIK: 0001649989 (see all company filings)

IRS No.: 383982704 | Fiscal Year End: 0930
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ONCOBIOLOGICS, INC. 7 CLARKE DRIVE CRANBURY NJ 08512
Business Address
Dyrness Albert D. (Reporting) CIK: 0001664801 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37759 | Film No.: 161644932